𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of treatment effects in Alzheimer's and other neurodegenerative diseases by MRI and MRS

✍ Scribed by S. G. Mueller; N. Schuff; M. W. Weiner

Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
431 KB
Volume
19
Category
Article
ISSN
0952-3480

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Paradigm shifts in Alzheimer's disease a
Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: The emerging role of oligomeric assemblies
✍ Marina D. Kirkitadze; Gal Bitan; David B. Teplow πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 112 KB

Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by amyloid deposition in the cerebral neuropil and vasculature. These amyloid deposits comprise predominantly fragments and full-length (40 or 42 residue) forms of the amyloid beta-protein (Abeta) organized into fibr

Detecting treatment effects with combina
Detecting treatment effects with combinations of the ADAS-cog items in patients with mild and moderate Alzheimer's disease
✍ Ralf Ihl; Steven Ferris; Philippe Robert; Bengt Winblad; Serge Gauthier; Frank T πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 147 KB πŸ‘ 2 views

## Abstract ## Objective When complex cognitive functions are measured with multi‐item scales like the Alzheimer's Disease Assessment Scale – cognitive subscale (ADAS‐cog), it seems valuable information can be lost due to combination of the ADAS‐cog items results into a total score. We hypothesize